Abstract | OBJECTIVE: Inadequate dietary fiber intake is a widely accepted explanation for chronic constipation in children with severe brain damage. The aim of our study was to evaluate the efficacy of glucomannan, a soluble fiber, as a treatment for chronic constipation in these children. STUDY DESIGN: Twenty children with severe brain damage and chronic constipation were randomly assigned to double-blind treatment with either glucomannan (n = 10) or placebo (n = 10) for 12 weeks. Stool habits, total and segmental gastrointestinal transit times, and anorectal motility were evaluated in all children before and after the treatment period. RESULTS:
Glucomannan significantly increased (P <.01) stool frequency, whereas the effect of placebo was not significant. Laxative or suppository use was significantly reduced (P <.01) by glucomannan but was not affected by placebo. Clinical scores of stool consistency were significantly improved and episodes of painful defecation per week were significantly reduced by glucomannan (P <.01) but not by placebo. However, neither glucomannan nor placebo had a measurable effect on total and segmental transit times. CONCLUSIONS: In neurologically impaired children, glucomannan improves stool frequency but has no effect on colonic motility.
|
Authors | A Staiano, D Simeone, E Del Giudice, E Miele, A Tozzi, C Toraldo |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 136
Issue 1
Pg. 41-5
(Jan 2000)
ISSN: 0022-3476 [Print] United States |
PMID | 10636972
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cathartics
- Dietary Fiber
- Mannans
- Placebos
- Suppositories
- (1-6)-alpha-glucomannan
|
Topics |
- Administration, Rectal
- Anal Canal
(physiology)
- Brain Damage, Chronic
(complications)
- Cathartics
(therapeutic use)
- Child, Preschool
- Chronic Disease
- Colon
(physiology)
- Constipation
(diet therapy)
- Defecation
(physiology)
- Dietary Fiber
(therapeutic use)
- Double-Blind Method
- Feces
- Female
- Follow-Up Studies
- Gastrointestinal Motility
(physiology)
- Gastrointestinal Transit
(physiology)
- Humans
- Intellectual Disability
(complications)
- Male
- Mannans
(therapeutic use)
- Placebos
- Rectum
(physiology)
- Suppositories
|